Key result
Elevated ADMA levels appear to be a risk marker for death, cardiovascular mortality, and renal progression in patients with kidney failure, though causality remains unproven.
Design
Editorial
Authors
Loading...
While ADMA is a strong independent predictor of cardiovascular and renal outcomes in kidney disease, its role as a causal mediator rather than a mere marker requires further experimental validation.
While ADMA is a strong independent predictor of cardiovascular and renal outcomes in kidney disease, its role as a causal mediator rather than a mere marker requires further experimental validation.
Vallance et al. (2005) conducted an editorial in Kidney disease. Asymmetric Dimethylarginine (ADMA) was evaluated. Elevated ADMA levels appear to be a risk marker for death, cardiovascular mortality, and renal progression in patients with kidney failure, though causality remains unproven.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: